Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 4/20 | 0.47 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25760149 | 0.87 | KMT2A (0.42) | GABRA1GABRB1GLRA1GAALMNA | |
| SCHEMBL12446747 | 0.79 | HPGD (0.38) | GABRA1GABRB1GAAHTTLMNA | |
| SCHEMBL27584559 | 0.78 | GABRA1 (0.53) | GABRA1GABRB1CA1CA2GLRA1 | |
| SCHEMBL2484139 | 0.77 | GABRA1 (0.51) | GABRA1GABRB1CA1CA2GLRA1 | |
| SCHEMBL2482630 | 0.77 | GABRA1 (0.51) | GABRA1GABRB1CA1CA2GLRA1 | |
| SCHEMBL2485093 | 0.77 | GABRA1 (0.51) | GABRA1GABRB1CA1CA2GLRA1 | |
| SCHEMBL9246992 | 0.76 | KDM4E (0.46) | CA1CA2GAAHTTLMNA | |
| SCHEMBL9246954 | 0.75 | CA12 (0.46) | CA1CA2CYP3A4EGFR | |
| SCHEMBL21660797 | 0.75 | GABRA1 (0.50) | GABRA1GABRB1CA1CA2GLRA1 | |
| Acrylic Acid SCHEMBL30923509 | 0.74 | CA1 (0.50) | GABRA1GABRB1CA1CA2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11684590-B2 | Substituted alkylphenols as HCN1 antagonists | CORNELL UNIVERSITY (US) | 2023-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684590-B2 | Substituted alkylphenols as HCN1 antagonists | HCN1, HCN2, HCN3 | GABRA1 423/4885GABRB1 312/4885CA1 2932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.